Aminoisoxazoline Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors
申请人:Forum Pharmaceuticals, Inc.
公开号:US20170247393A1
公开(公告)日:2017-08-31
The present invention relates to novel aminoisoxazoline compounds, and pharmaceutical compositions of the same, that are suitable as agonists or partial agonists of α7-nAChR, and methods of preparing these compounds and compositions, and the use of these compounds and compositions in methods of maintaining, treating and/or improving cognitive function. In particular, methods of administering the compound or composition to a patient in need thereof, for example a patient with a cognitive deficiency and/or a desire to enhance cognitive function, that may derive a benefit therefrom.